MedPath

Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-I: Prospective observational study

Not Applicable
Conditions
first relapsed acute lymphoblastic leukemia in children
Registration Number
JPRN-UMIN000002026
Lead Sponsor
Japanese Peditric Leukemia/Lymphoma Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
88
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with mature B-ALL, Ph chromosome positive ALL or MLL gene rearrangement positive ALL.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3 year-event free survival rate(3y-EFS), 3 year-overall survival rate(3y-OS)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath